(Q45856592)

17 December 2017

title

The Absorption of Human Factor VIII Neutralizing Antibody by Factor VIII (English)

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1974.TB00471.X

11 March 2023

author name string

R. Biggs

1

1 reference

PubMed ID

4843742

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4843742

11 March 2023

language of work or name

English

0 references

publication date

1 February 1974

1 reference

17 December 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1365-2141.1974.tb00471.x

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1974.TB00471.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.1974.tb00471.x/fullpdf

11 March 2023

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1974.TB00471.X

British Journal of Haematology

11 March 2023

published in

1 reference

17 December 2017

volume

26

1 reference

17 December 2017

page(s)

259-267

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

Hemophilia A: polymorphism detectable by a factor 8 antibody

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1974.TB00471.X

Immune response to chemically modified flagellin. I. Induction of antibody tolerance to flagellin by acetoacetylated derivatives of the protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.1974.TB00471.X

Thrombosis et diathesis haemorrhagica

21 January 2018

1

18

354

Abilgaard C.F.

1967

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1974.TB00471.X

Thiol Groups in the Blood Clotting Action of Factor VIII

11 March 2023

2

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1974.TB00471.X

Immunological differentiation of three types of haemophilia and identification of some female carriers

11 March 2023

3

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1974.TB00471.X

The mode of action of antibodies which destroy factor VIII. I. Antibodies which have second-order concentration graphs

11 March 2023

5

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1974.TB00471.X

A method for the study of antihaemophilic globulin inhibitors with reference to six cases

11 March 2023

6

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1974.TB00471.X

Two Types of Haemophilia (A+and A−): A Study of 48 Cases

11 March 2023

7

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1974.TB00471.X

Methods for the production of clinically effective intermediate- and high-purity factor-VIII concentrates

11 March 2023

10

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1974.TB00471.X

The Treatment of Patients who have Factor-VIII Antibodies

11 March 2023

12

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1974.TB00471.X

Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant agains

11 March 2023

13

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.1974.TB00471.X

11 March 2023

Identifiers

1 reference

17 December 2017

PubMed ID

4843742

1 reference

17 December 2017